Reference: 38 CFR 4.75-4.79

Sources & Related Guides

What is the VA rating for Eye Conditions?

Review Eye Conditions guidance covering roughly 39 diagnostic codes (DC 6000-6091), the combined two-eye visual-acuity tables (DC 6061-6066), the General Rating Formula for Diseases of the Eye (incapacitating episodes or visual impairment, whichever is higher), visual field defects (DC 6080), scotoma (DC 6081), and diplopia's acuity-equivalent conversion (DC 6090).

Condition Overview & Clinical Scope

VA rates eye conditions under 38 CFR 4.75-4.79 -- section 4.79's roughly 39 diagnostic codes (DC 6000-6091), most of which route into the General Rating Formula for Diseases of the Eye (incapacitating episodes, or visual impairment due to the condition, whichever is higher). Visual impairment itself is computed through methodology sections 4.75-4.78: central visual acuity (the combined two-eye tables at DC 6061-6066), visual fields (DC 6080-6081), and muscle function/diplopia (DC 6090). This hub combines a large number of diagnosis labels, roughly 39, with a structurally complex design: a small number of genuinely shared computational engines cover all of them, not 39 independent formulas.

EXPLORE THIS CONDITION

Explore Eye Conditions Criteria & Tools

Save this condition to find it again later. Saved only on this device and browser. Never sent to RatingScope. Lost if you clear browser data or switch devices or browsers.

Overview

About this condition

VA rates eye conditions under 38 CFR 4.75-4.79 -- section 4.79's roughly 39 diagnostic codes (DC 6000-6091), most of which route into the General Rating Formula for Diseases of the Eye (incapacitating episodes, or visual impairment due to the condition, whichever is higher). Visual impairment itself is computed through methodology sections 4.75-4.78: central visual acuity (the combined two-eye tables at DC 6061-6066), visual fields (DC 6080-6081), and muscle function/diplopia (DC 6090). This hub combines a large number of diagnosis labels, roughly 39, with a structurally complex design: a small number of genuinely shared computational engines cover all of them, not 39 independent formulas.

Regulatory authority: 38 CFR 4.75-4.79, Diagnostic Codes 6000-6091

This hub explains the published DC 6000-6091 schedule and its methodology sections (38 CFR 4.75-4.79) and common record language. It does not diagnose an eye condition, determine service connection, infer undocumented findings, estimate an outcome, or replace medical care or accredited representation. IMPORTANT DISCLOSURES: (1) DC 6026 (optic neuropathy), DC 6035 (keratoconus), DC 6040 (diabetic retinopathy), DC 6042 (retinal dystrophy), and DC 6046 (post-chiasmal disorders) carry NO rating text of their own in the current published schedule -- confirmed by direct primary-source fetch, not silently assumed to default to the General Rating Formula. This is disclosed as a genuine, unresolved textual gap; RatingScope computes no result for any of these five diagnoses in either direction. (2) DC 6014 (malignant neoplasm), DC 6015 (benign neoplasm), and DC 6032 (loss of eyelids) each direct 'separately evaluate visual and nonvisual impairment (e.g., disfigurement, DC 7800), and combine the evaluations' -- a genuinely open-ended nonvisual component (no closed list of destination codes is named, only an illustrative example), more open-ended than a standard predominant-disability deferral. RatingScope computes the visual-impairment component directly and discloses the nonvisual component for separate review, never auto-combining a single number. (3) DC 6034 (pterygium) and DC 6091 (symblepharon) are NOT a pick-one predominant-finding dispatch -- their own text says to evaluate under multiple named codes (the General Rating Formula, DC 7800, DC 6018, etc., depending on findings) and COMBINE them under 38 CFR 4.25. RatingScope computes the General Rating Formula component directly and discloses the combination step, with a link to RatingScope's own Combined Ratings calculator, never auto-computing the combined number itself. (4) DC 6010 (tuberculosis of eye)'s inactive-phase cross-reference to 38 CFR 4.88c or 4.89 is now fully modeled, not merely disclosed: active tuberculosis is a flat 100 percent (stated directly in DC 6010's own text); inactive tuberculosis is gated by §4.88c's own 1-year 100 percent floor (post-August-19-1968 entitlement) or §4.89's own 2-year 100 percent floor plus its 6-year and 11-year graduated 50/30 percent floors (pre-August-19-1968, closed population), asked as a direct entitlement-basis fact, before dispatching to this hub's own visual-acuity residual scale -- the same active/inactive TB dispatch shape already used for Genitourinary's DC 7505/7525.

Percentage Guides

Understanding Your Percentage

Select a pathway to see what the published criteria ask about, what records may clarify it, and what should not be assumed.

Varies (0-100%), General Rating Formula

Highest listed pathway

Most eye diagnoses are rated on whichever is higher: documented incapacitating episodes (treatment visits in the past 12 months) or visual impairment due to the condition.

What separates the next level: Visual impairment itself is computed through the combined visual-acuity tables (DC 6061-6066), visual field tables (DC 6080-6081), or diplopia conversion (DC 6090) -- whichever applies to the documented findings.

Review CFR criteria, examples, and evidence
Official CFR language
Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation. 7 or more treatment visits -- 60; 5 to 6 -- 40; 3 to 4 -- 20; 1 to 2 -- 10.
Qualification explanation
The General Rating Formula for Diseases of the Eye applies by default to most diagnosis labels in this hub that carry no independent criteria of their own.
Examples
Records document 4 treatment visits in the past 12 months for choroidopathy, and visual acuity that would independently compute to only 10 percent -- the 20 percent incapacitating-episode tier controls.
Medical evidence
Eye Conditions DBQ; Treatment visit records; Visual acuity, visual field, or diplopia measurements
Functional impact examples
Documented eye disease requiring recurring treatment, or measurable visual impairment.
Common misconceptions
The two paths are compared with 'whichever is higher,' not combined -- this is a direct comparison (Math.max), not a §4.25 combined-ratings calculation.
Related topics
visual-acuity-tables
Source context
38 CFR 4.79; General Rating Formula; Current DC 6000-6091 educational pathway. No pending rulemaking found touching §§4.75-4.79 as of RSCH-035 (2026-07-25).

100% (DC 6010, tuberculosis of eye, active)

Highest listed pathway

Active tuberculosis of the eye is a flat 100 percent, stated directly.

What separates the next level: Inactive tuberculosis of the eye is gated by §4.88c/§4.89's own time-and-floor mechanic before dispatching to this hub's own visual-acuity residual scale -- the same active/inactive TB shape already used for Genitourinary's DC 7505/7525.

Review CFR criteria, examples, and evidence
Official CFR language
6010 Tuberculosis of eye: Active -- 100. Inactive: Evaluate under §4.88c or §4.89 of this part, whichever is appropriate.
Qualification explanation
No further findings are needed once active status is confirmed.
Examples
Records document currently active tuberculosis of the eye.
Medical evidence
Eye Conditions DBQ; Records confirming active/inactive tuberculosis status
Functional impact examples
Active ocular tuberculosis infection.
Common misconceptions
The §4.88c/§4.89 citation only governs the inactive phase -- the active phase's 100 percent is stated directly in DC 6010's own text, no cross-reference needed.
Related topics
dc6010-tb
Source context
38 CFR 4.79; 6010; Current DC 6010 educational pathway.

100% (DC 6010, tuberculosis of eye, inactive, within the mandatory time floor)

Highest listed pathway

Inactive tuberculosis of the eye is still a flat 100 percent for a mandatory window after the date of inactivity, before any visual-acuity finding is even considered: 1 year for entitlement established after August 19, 1968 (§4.88c), or 2 years for entitlement established on or before that date (§4.89, a closed population).

What separates the next level: Once the mandatory 1-year (§4.88c) or 2-year (§4.89) window has passed, §4.89's own text adds a further graduated floor (50 percent for years 2-6, 30 percent for years 6-11) that the residual scale can exceed but never fall below; §4.88c has no further floor beyond its own 1-year window.

Review CFR criteria, examples, and evidence
Official CFR language
§4.88c: 'For 1 year after date of inactivity, following active tuberculosis -- 100. Thereafter: Rate residuals under the specific body system or systems affected.' §4.89: 'For 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently -- 100.'
Qualification explanation
This floor is unconditional -- it applies regardless of what visual acuity is documented, and is never displaced by a lower residual finding.
Examples
Records document inactive tuberculosis of the eye, entitlement established in 2005 (post-1968), 4 months since the date of inactivity -- the 100 percent floor controls regardless of documented visual acuity.
Medical evidence
Eye Conditions DBQ; Records confirming the date of inactivity and the entitlement-basis date
Functional impact examples
Recently inactivated ocular tuberculosis, within the mandatory statutory floor window.
Common misconceptions
This floor was previously not modeled at all -- RatingScope's earlier behavior dispatched every inactive finding straight to the visual-acuity residual scale, which could silently under-rate a veteran still inside this mandatory window. Corrected under BUG-152.
Related topics
dc6010-tb
Source context
38 CFR 4.88c/4.89; 6010; Current DC 6010 educational pathway, per RSCH-091.

50% or 30% minimum (DC 6010, tuberculosis of eye, inactive, §4.89 graduated floor)

Highest listed pathway

For the closed §4.89 population only (entitlement on or before August 19, 1968), years 2 through 6 since the date of inactivity carry a 50 percent floor, and years 6 through 11 carry a 30 percent floor -- the visual-acuity residual scale is used only if it computes higher than the floor.

What separates the next level: Beyond 11 years since the date of inactivity, §4.89's floor no longer applies and the visual-acuity residual scale controls alone, including its own 0 percent row if no compensable finding is documented.

Review CFR criteria, examples, and evidence
Official CFR language
'Thereafter, for 4 years, or in any event, to 6 years after date of inactivity -- 50. Thereafter, for 5 years, or to 11 years after date of inactivity -- 30... if in excess of 50 percent or 30 percent will be assigned under the appropriate diagnostic code for the specific residual.'
Qualification explanation
The higher of the stated floor or the visual-acuity residual controls (Math.max), never the floor and the residual added or combined together.
Examples
§4.89 population, 4 years since the date of inactivity, visual acuity computing to 20 percent under the residual scale -- the 50 percent floor controls (60 vs 20, higher wins is actually 50 here since floor is 50).
Medical evidence
Eye Conditions DBQ; Records confirming the date of inactivity and the entitlement-basis date; Visual acuity for both eyes
Functional impact examples
§4.89-population inactive ocular tuberculosis, years 2-11 since inactivity.
Common misconceptions
This graduated floor was previously not modeled at all, in either direction -- corrected under BUG-152. §4.89's own text also states this graduated rating will not be combined with a separate residual rating under 38 CFR 4.25 unless the two cover genuinely separate functional losses, a nuance RatingScope discloses rather than auto-resolves.
Related topics
dc6010-tb
Source context
38 CFR 4.89; 6010; Current DC 6010 educational pathway, per RSCH-091.

10% minimum (DC 6012/6013, glaucoma requiring continuous medication)

Next: 20%

Glaucoma requiring continuous medication carries its own 10 percent minimum, even if visual impairment alone would compute lower.

What separates the next level: Without a continuous-medication requirement, glaucoma is rated purely under the General Rating Formula, which can resolve to 0 percent.

Review CFR criteria, examples, and evidence
Official CFR language
Evaluate under the General Rating Formula for Diseases of the Eye. Minimum evaluation if continuous medication is required -- 10.
Qualification explanation
The 10 percent floor applies on top of the General Rating Formula, whichever is higher.
Examples
Records document open-angle glaucoma requiring daily eye drops, with visual acuity that would otherwise compute to 0 percent -- the 10 percent minimum controls.
Medical evidence
Eye Conditions DBQ; Medication records
Functional impact examples
Glaucoma managed with ongoing medication.
Common misconceptions
This minimum applies specifically to the continuous-medication finding -- it is not automatic for every glaucoma diagnosis.
Related topics
visual-acuity-tables
Source context
38 CFR 4.79; 6012/6013; Current DC 6012/6013 educational pathway.

100% (DC 6014, malignant neoplasm requiring systemic-comparable therapy)

Highest listed pathway

A malignant neoplasm of the eye, orbit, or adnexa requiring therapy comparable to systemic malignancy treatment is a flat 100 percent, continuing through treatment.

What separates the next level: A malignant neoplasm not requiring comparable therapy is rated on its visual-impairment component alone, with the nonvisual (e.g. disfigurement) component disclosed for separate review.

Review CFR criteria, examples, and evidence
Official CFR language
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies -- 100.
Qualification explanation
No visual-acuity findings are needed once this therapy requirement is confirmed.
Examples
Records document a malignant orbital neoplasm requiring systemic chemotherapy.
Medical evidence
Eye Conditions DBQ; Oncology treatment records
Functional impact examples
Malignant eye/orbit neoplasm under active systemic-comparable treatment.
Common misconceptions
This 100 percent continues beyond the cessation of treatment until a mandatory VA examination 6 months later re-evaluates residuals -- disclosed as context, not modeled as a computed transition.
Related topics
neoplasm-combine
Source context
38 CFR 4.79; 6014; Current DC 6014 educational pathway.

30 percent minimum, elevated one step (DC 6029, aphakia)

Highest listed pathway

Aphakia (absence of the eye's natural or replacement lens) is rated on visual impairment, elevated one step worse, with a 30 percent minimum.

What separates the next level: Cataract with a replacement lens (pseudophakia) is rated under the General Rating Formula directly, without this elevation or minimum.

Review CFR criteria, examples, and evidence
Official CFR language
Evaluate based on visual impairment, and elevate the resulting level of visual impairment one step. Minimum (unilateral or bilateral) -- 30.
Qualification explanation
The raw visual-acuity-derived percentage is moved one step worse on the schedule's own step sequence before the 30 percent minimum is applied.
Examples
Records document aphakia following cataract surgery with no replacement lens, and visual acuity that raw-computes to 20 percent -- elevated to 30 percent, which also happens to equal the minimum.
Medical evidence
Eye Conditions DBQ; Surgical records confirming no replacement lens
Functional impact examples
Absence of a natural or replacement lens following cataract surgery.
Common misconceptions
Cataract with NO replacement lens is rated as aphakia under this same mechanic -- cataract with a replacement lens is not.
Related topics
visual-acuity-tables
Source context
38 CFR 4.79; 6029; Current DC 6029 educational pathway.

0% (DC 6090, diplopia, occasional or spectacle-correctable)

Next: 10%

Diplopia (double vision) that is occasional or correctable with spectacles is rated at 0 percent.

What separates the next level: Diplopia that is constant and not correctable is converted to a visual-acuity equivalent for the affected eye via §4.78(b), then combined against the fellow eye's real acuity.

Review CFR criteria, examples, and evidence
Official CFR language
In accordance with 38 CFR 4.31, diplopia that is occasional or that is correctable with spectacles is evaluated at 0 percent.
Qualification explanation
DC 6090's own Note invokes §4.31 (the general 0 percent default rule) by section number.
Examples
Records document diplopia only when looking in an extreme direction, fully correctable with prism glasses.
Medical evidence
Eye Conditions DBQ
Functional impact examples
Diplopia with minimal functional impact due to occasional occurrence or spectacle correction.
Common misconceptions
This 0 percent is an explicit, real registry outcome, not an absence-of-criteria default.
Related topics
diplopia
Source context
38 CFR 4.78; 6090; Current DC 6090 educational pathway.

Varies (10-100%), Visual Field Defects (DC 6080)

Highest listed pathway

Visual field loss is rated on a table of named defect patterns -- homonymous hemianopsia, loss of a visual field half, or concentric contraction of the remaining field -- with bilateral involvement rated the same as or higher than unilateral involvement at every row, up to a flat 100 percent for bilateral concentric contraction down to 5 degrees remaining.

What separates the next level: Every row also allows an alternative: evaluating each affected eye at a stated visual-acuity equivalent instead (for example, unilateral loss of the temporal half may instead be evaluated as 20/70 in the affected eye) -- whichever produces the higher evaluation controls, the same 'whichever is higher' comparison used throughout this hub.

Review CFR criteria, examples, and evidence
Official CFR language
6080 Visual field defects: Homonymous hemianopsia -- 30. Loss of temporal half of visual field: Bilateral -- 30, Unilateral -- 10 (or evaluate each affected eye as 20/70). Loss of nasal half of visual field: Bilateral -- 10, Unilateral -- 10 (or evaluate each affected eye as 20/50). Loss of inferior half of visual field: Bilateral -- 30, Unilateral -- 10 (or evaluate each affected eye as 20/70). Loss of superior half of visual field: Bilateral -- 10, Unilateral -- 10 (or evaluate each affected eye as 20/50). Concentric contraction of visual field, remaining field of 5 degrees: Bilateral -- 100, Unilateral -- 30 (or evaluate each affected eye as 5/200); 6 to 15 degrees: Bilateral -- 70, Unilateral -- 20 (or evaluate each affected eye as 20/200); 16 to 30 degrees: Bilateral -- 50, Unilateral -- 10 (or evaluate each affected eye as 20/100); 31 to 45 degrees: Bilateral -- 30, Unilateral -- 10 (or evaluate each affected eye as 20/70); 46 to 60 degrees: Bilateral -- 10, Unilateral -- 10 (or evaluate each affected eye as 20/50).
Qualification explanation
Each defect pattern and degree range is its own row on the table; the specific pattern documented on visual field testing (not visual acuity) determines which row applies.
Examples
Automated perimetry documents bilateral concentric contraction with only 5 degrees of visual field remaining in each eye -- rated 100 percent.
Medical evidence
Eye Conditions DBQ; Goldmann or automated perimetry (visual field) testing
Functional impact examples
Documented visual field loss on perimetry testing, distinct from a visual acuity (Snellen) measurement.
Common misconceptions
Visual field loss is measured and rated separately from visual acuity -- a normal Snellen acuity reading does not rule out a compensable visual field defect.
Related topics
visual-field-tables
Source context
38 CFR 4.79; 6080; Current DC 6080 educational pathway.

10% minimum (DC 6081, unilateral scotoma), or evaluate as visual impairment if higher

Highest listed pathway

A unilateral scotoma (blind spot) affecting at least one-quarter of the visual field, or a centrally located scotoma of any size, carries a 10 percent minimum -- with the alternative of evaluating the underlying visual impairment directly if that produces a higher result.

What separates the next level: If the scotoma's actual visual impairment would compute higher than 10 percent under the visual-field or visual-acuity tables, that higher figure is used instead, the same 'whichever is higher' comparison used throughout this hub.

Review CFR criteria, examples, and evidence
Official CFR language
6081 Scotoma, unilateral: Minimum, with scotoma affecting at least one-quarter of the visual field (quadrantanopsia) or with centrally located scotoma of any size -- 10. Alternatively, evaluate based on visual impairment due to scotoma, if that would result in a higher evaluation.
Qualification explanation
The 10 percent minimum applies once either the one-quarter-of-field or centrally-located threshold is met; it is a floor, not a ceiling.
Examples
Perimetry documents a unilateral centrally located scotoma smaller than one-quarter of the visual field, too small to independently reach 10 percent under the visual impairment tables -- the 10 percent minimum controls.
Medical evidence
Eye Conditions DBQ; Goldmann or automated perimetry (visual field) testing
Functional impact examples
Documented unilateral scotoma (blind spot) on visual field testing.
Common misconceptions
This minimum is specific to scotoma meeting the one-quarter-of-field or centrally-located threshold -- it is not a general floor for every visual field finding.
Related topics
visual-field-tables
Source context
38 CFR 4.79; 6081; Current DC 6081 educational pathway.

Learn

Understand the details behind the criteria

Use these short guides to connect published terms with the records and observations that may clarify them.

How the combined visual-acuity tables work (DC 6061-6066)

Visual impairment is computed by combining both eyes' documented status (anatomical loss, no more than light perception, or a measured Snellen acuity band) through a set of tables: DC 6061/6062 (both eyes at the same severe status, flat 100 percent), DC 6063/6064/6065 (one eye at a severe status, an 8-row ladder keyed by the other eye's band), or DC 6066 (both eyes measured at 10/200 or better, a 28-cell matrix).

  • DC 6064 (light-perception-only) and DC 6065 (fixed at 5/200) share numerically identical ladders, row for row -- they differ only in which row carries the special-monthly-compensation review footnote (DC 6064's covers the whole code; DC 6065's covers only its own worst row).
  • §4.78's own text: when only one eye is service-connected, the OTHER eye's actual documented acuity is never used as the second input -- it is always treated as 20/40 (the best non-compensable rung) instead.
  • DC 6066's matrix is printed as a triangular half-grid, not a full square -- the schedule relies on the two eyes being interchangeable rather than printing every combination twice.

Records to review: Eye Conditions DBQ; Visual acuity measurements for both eyes.

5 diagnoses with no rating text of their own

DC 6026 (optic neuropathy), DC 6035 (keratoconus), DC 6040 (diabetic retinopathy), DC 6042 (retinal dystrophy), and DC 6046 (post-chiasmal disorders) carry no percentage or 'evaluate under...' instruction in the current published schedule at all -- confirmed by direct fetch of the primary source text, not assumed.

  • VA's own 2018 rulemaking preamble explicitly names DC 6026 and DC 6046 as having had 'redundant' General-Rating-Formula-default language deliberately removed, since the formula's own introductory note already covers every diagnosis in this table by default.
  • The same preamble does NOT name DC 6035, DC 6040, or DC 6042 for that same rationale anywhere in its text -- leaving genuinely open whether all five default identically, or whether some are label-only diagnostic entries never independently rated.
  • RatingScope computes no result for any of these five diagnoses in either direction -- this is disclosed as an unresolved gap, not silently resolved by assuming the General Rating Formula applies.

Records to review: Eye Conditions DBQ (documents these diagnoses as real diagnostic categories, but does not resolve which rating mechanism applies).

Neoplasms and eyelid loss: an open-ended nonvisual component

DC 6014 (malignant neoplasm not requiring systemic-comparable therapy), DC 6015 (benign neoplasm), and DC 6032 (loss of eyelids) each direct 'separately evaluate visual and nonvisual impairment (e.g., disfigurement, DC 7800), and combine the evaluations' -- naming DC 7800 only as an illustrative example, not a closed destination list.

  • This is genuinely more open-ended than a standard predominant-disability deferral (which typically names a fixed, closed set of destination codes) -- here, no closed set is named at all.
  • RatingScope computes the visual-impairment component directly through the combined acuity tables, and discloses the nonvisual component (disfigurement or otherwise) for separate review -- it never guesses or auto-combines a single final number.
  • If your records document facial or orbital disfigurement alongside one of these diagnoses, review RatingScope's Scars hub separately, then combine both results using RatingScope's own Combined Ratings calculator.

Records to review: Eye Conditions DBQ; Surgical or examination records documenting the nonvisual finding.

DC 6034/6091: combine under §4.25, not a predominant-finding pick

Pterygium (DC 6034) and symblepharon (DC 6091) direct evaluation under multiple named codes (the General Rating Formula, DC 7800, DC 6018, or others, 'depending on the particular findings') and COMBINE them under 38 CFR 4.25 -- this is a combine-multiple-findings instruction, not a single-winner predominant-finding selection.

  • A prior framing of this pair as a '3-way predominant finding dispatch' was checked directly against the verbatim eCFR text during this hub's build and corrected -- the text says 'combine,' not 'whichever is predominant.'
  • RatingScope computes the General Rating Formula component directly; any additional named finding (disfigurement, conjunctivitis, or another applicable code) is disclosed for separate evaluation, with a link to RatingScope's own Combined Ratings calculator to combine the results -- never an auto-computed single number.
  • This mirrors the same disclosure discipline already used for other cross-code combination points in this repository -- never silently dispatched into another hub's own facts.

Records to review: Eye Conditions DBQ; Records documenting each applicable finding.

DC 6010: tuberculosis of the eye, the full §4.88c/§4.89 TB dispatch

Active tuberculosis of the eye is a flat 100 percent, stated directly. Inactive tuberculosis is gated by §4.88c's 1-year 100 percent floor (post-1968 entitlement) or §4.89's 2-year 100 percent floor plus its 6-year and 11-year graduated 50/30 percent floors (pre-1968, closed population), before dispatching to this hub's own visual-acuity residual scale -- the same active/inactive TB dispatch shape already used for Genitourinary's DC 7505/7525.

  • DC 6010's inactive-phase text cites '§4.88c or §4.89, whichever is appropriate' -- a determinable fact (tuberculosis entitlement before or after August 19, 1968), not a clinical judgment call, per RSCH-091's cross-condition research.
  • RatingScope models which of §4.88c or §4.89 applies as its own direct fact (entitlement basis), then the mandatory time floor (1 year for §4.88c, 2 years for §4.89), then, for §4.89 only, a graduated floor for years 2-6 (50 percent) and years 6-11 (30 percent) -- the higher of the floor or the visual-acuity residual controls, never both summed. Beyond §4.88c's 1 year, or §4.89's 11 years, the residual scale alone controls.
  • Corrected under BUG-152: earlier RatingScope behavior dispatched every inactive finding straight to the visual-acuity residual scale with no time gating at all, silently skipping these mandatory floors -- a live accuracy defect, not merely an undisclosed nuance.
  • §4.89's own text states its graduated rating 'will not be combined with residuals of nonpulmonary tuberculosis unless the graduated rating and the rating for residual disability cover separate functional losses' -- RatingScope discloses this rather than auto-resolving it, since distinguishing genuinely separate functional losses from the same underlying residual is a clinical judgment this hub does not make.

Records to review: Eye Conditions DBQ; Records confirming active/inactive tuberculosis status, the entitlement-basis date, and the date of inactivity.

How diplopia converts to a visual-acuity equivalent

Diplopia (double vision) is rated by converting the documented quadrant and degree range into an acuity-equivalent for the affected eye (§4.78(b)(1)), which is then combined against the fellow eye's real (or service-connection-substituted) acuity through the same tables used for every other visual-impairment computation.

  • When diplopia spans more than one quadrant, the quadrant/degree combination producing the highest evaluation controls.
  • When diplopia exists in two separate areas of the same eye, the acuity-equivalent is bumped one step worse (not to exceed 5/200) before combination.
  • Occasional or spectacle-correctable diplopia is rated at 0 percent under §4.31, regardless of quadrant or degree.

Records to review: Eye Conditions DBQ; Muscle-function/diplopia examination documenting quadrant, degree, and frequency.

How the visual field defect tables work (DC 6080-6081)

Visual field impairment is rated separately from visual acuity, on its own table of named defect patterns: DC 6080 covers homonymous hemianopsia, loss of a visual field half (temporal, nasal, inferior, or superior), and concentric contraction of the remaining field (a 5-tier ladder by degrees remaining); DC 6081 covers a unilateral scotoma with a 10 percent minimum. Every DC 6080 row also allows an alternative: evaluating the affected eye at a stated visual-acuity equivalent instead, whichever is higher.

  • DC 6080's concentric contraction ladder is the only visual field row that reaches 100 percent -- bilateral involvement with only 5 degrees of field remaining in each eye.
  • Every DC 6080 defect pattern lists two ratings (bilateral and unilateral) paired with an alternative acuity-equivalent option: for example, loss of the temporal half of the visual field is rated 30 percent bilateral or 10 percent unilateral, or each affected eye may instead be evaluated as 20/70 -- whichever produces the higher evaluation.
  • DC 6081 (unilateral scotoma) is a minimum-percentage floor, not a table -- 10 percent once the scotoma affects at least one-quarter of the visual field or is centrally located of any size, with the alternative of rating the underlying visual impairment directly if that computes higher.

Records to review: Eye Conditions DBQ; Goldmann or automated perimetry (visual field) testing.

Evidence

Evidence that may clarify the published criteria

Visual acuity measurements for both eyes

The primary input to the combined visual-acuity tables (DC 6061-6066) used across most diagnosis labels in this hub.

Not required for flat-percentage labels (nystagmus, loss of eyebrows/eyelashes, paralysis of accommodation) or the laterality-only labels (ectropion, entropion, lagophthalmos, lacrimal disorders).

Treatment-visit records (incapacitating episodes)

Establishes the incapacitating-episode side of the General Rating Formula's 'whichever is higher' comparison.

Only relevant to diagnosis labels that route through the General Rating Formula.

Eye Conditions Disability Benefits Questionnaire

The standardized VA exam form covering visual acuity, visual fields, diplopia, and disease-specific diagnosis checklists.

A DBQ is one common evidence source, not the only way to document these findings.

Official VA Forms & DBQs

Downloadable DBQs & Supporting Claim Forms

Take the public DBQ to your private physician or review it prior to your C&P examination.

Terminology

Plain-English terms

Visual impairment / vision loss

"Vision loss" and "visual impairment" are the everyday terms for what this hub calls central visual acuity, visual field, or anatomical-loss findings -- whichever measured or documented finding applies determines the pathway, not the general phrase itself.

Records may describe this using lay language (vision loss, blindness, impaired vision) rather than the regulation's own terms; RatingScope reads whichever specific, documented finding (acuity, field, anatomical loss) is actually present.

Ophthalmology examination records; Visual acuity and visual field testing; visual-acuity-tables

Anatomical loss

The eye itself is gone, not just impaired.

Drives the DC 6061/6063 ladder rather than a measured Snellen acuity.

Surgical or examination records; visual-acuity-tables

Aphakia

No lens at all in the eye, natural or artificial.

Triggers DC 6029's elevate-one-step-plus-30-percent-minimum mechanic, distinct from ordinary cataract rating.

Surgical records; visual-acuity-tables

TDIU

Even if the schedular rating for Eye Conditions does not reach 100 percent, TDIU may still provide a pathway to compensation at the 100 percent rate, based on unemployability from this and/or other service-connected disabilities combined.

A lower schedular percentage does not by itself foreclose TDIU eligibility -- this hub computes only the schedular percentage for this specific condition and does not determine TDIU eligibility.

Employment history; vocational impact documentation; occupational impairment

Common Questions

Questions veterans commonly ask

How does VA rate most eye conditions?

Most diagnosis labels in this hub route into the General Rating Formula for Diseases of the Eye: documented incapacitating episodes (treatment visits in the past 12 months) or visual impairment due to the condition, whichever is higher.

How does VA measure visual acuity for both eyes together?

Through a set of tables (DC 6061-6066) that combine each eye's documented status (anatomical loss, light-perception-only, or a measured Snellen band) into a single percentage. §4.78 substitutes a fixed 20/40 value for a non-service-connected eye rather than using its actual measured acuity.

Why do some diagnoses have no computed result?

DC 6026, 6035, 6040, 6042, and 6046 carry no rating text of their own in the current published schedule. RatingScope discloses this as a genuine gap rather than guessing whether the General Rating Formula applies by default.

Is pterygium rated by picking the single worst finding?

No -- DC 6034 (and DC 6091, symblepharon) direct evaluation under multiple applicable codes, combined under 38 CFR 4.25. RatingScope computes the General Rating Formula component directly and discloses the other findings for separate evaluation and combination, rather than picking one predominant finding or guessing a combined number.

How is tuberculosis of the eye rated?

Active tuberculosis of the eye is a flat 100 percent. Inactive tuberculosis dispatches to this hub's own visual-acuity residual scale, the same active/inactive TB dispatch already used for Genitourinary's DC 7505/7525.

How is diplopia (double vision) rated?

Diplopia is converted into a visual-acuity equivalent for the affected eye based on its quadrant and degree range, then combined against the fellow eye's real acuity through the same tables used elsewhere in this hub. Occasional or spectacle-correctable diplopia is rated 0 percent.

If my schedular rating for Eye Conditions is below 100%, can I still be compensated at the 100% rate?

Possibly, through TDIU (Total Disability rating based on Individual Unemployability, 38 CFR 4.16) -- a separate pathway to 100 percent compensation based on unemployability, from this and/or other service-connected disabilities combined, independent of whether the schedular rating itself reaches 100 percent. This hub computes only the schedular percentage and does not determine TDIU eligibility.

What separates the Varies (0-100%), General Rating Formula rating from adjacent levels?

Visual impairment itself is computed through the combined visual-acuity tables (DC 6061-6066), visual field tables (DC 6080-6081), or diplopia conversion (DC 6090) -- whichever applies to the documented findings.

What separates the 100% (DC 6010, tuberculosis of eye, active) rating from adjacent levels?

Inactive tuberculosis of the eye is gated by §4.88c/§4.89's own time-and-floor mechanic before dispatching to this hub's own visual-acuity residual scale -- the same active/inactive TB shape already used for Genitourinary's DC 7505/7525.

What separates the 100% (DC 6010, tuberculosis of eye, inactive, within the mandatory time floor) rating from adjacent levels?

Once the mandatory 1-year (§4.88c) or 2-year (§4.89) window has passed, §4.89's own text adds a further graduated floor (50 percent for years 2-6, 30 percent for years 6-11) that the residual scale can exceed but never fall below; §4.88c has no further floor beyond its own 1-year window.

What separates the 50% or 30% minimum (DC 6010, tuberculosis of eye, inactive, §4.89 graduated floor) rating from adjacent levels?

Beyond 11 years since the date of inactivity, §4.89's floor no longer applies and the visual-acuity residual scale controls alone, including its own 0 percent row if no compensable finding is documented.

What separates the 10% minimum (DC 6012/6013, glaucoma requiring continuous medication) rating from adjacent levels?

Without a continuous-medication requirement, glaucoma is rated purely under the General Rating Formula, which can resolve to 0 percent.

What separates the 100% (DC 6014, malignant neoplasm requiring systemic-comparable therapy) rating from adjacent levels?

A malignant neoplasm not requiring comparable therapy is rated on its visual-impairment component alone, with the nonvisual (e.g. disfigurement) component disclosed for separate review.

What separates the 30 percent minimum, elevated one step (DC 6029, aphakia) rating from adjacent levels?

Cataract with a replacement lens (pseudophakia) is rated under the General Rating Formula directly, without this elevation or minimum.

What separates the 0% (DC 6090, diplopia, occasional or spectacle-correctable) rating from adjacent levels?

Diplopia that is constant and not correctable is converted to a visual-acuity equivalent for the affected eye via §4.78(b), then combined against the fellow eye's real acuity.

What separates the Varies (10-100%), Visual Field Defects (DC 6080) rating from adjacent levels?

Every row also allows an alternative: evaluating each affected eye at a stated visual-acuity equivalent instead (for example, unilateral loss of the temporal half may instead be evaluated as 20/70 in the affected eye) -- whichever produces the higher evaluation controls, the same 'whichever is higher' comparison used throughout this hub.

What separates the 10% minimum (DC 6081, unilateral scotoma), or evaluate as visual impairment if higher rating from adjacent levels?

If the scotoma's actual visual impairment would compute higher than 10 percent under the visual-field or visual-acuity tables, that higher figure is used instead, the same 'whichever is higher' comparison used throughout this hub.

Ready when you are

Compare documented eye condition findings

Use the diagnosis, visual-acuity or field-defect band, and laterality language already documented in your records. Do not upload records or enter Social Security numbers, claim numbers, full dates of birth, or other sensitive identifiers. RatingScope does not infer missing findings.

Informational guidance only. RatingScope does not predict, decide, or guarantee VA outcomes.

Compare my eye condition records

Learn More

Continue Understanding

RatingScope resource

Glaucoma VA Rating Criteria Guide

Guide to DC 6012/6013 General Rating Formula, 10% continuous medication floor, and visual field progression.

Open Glaucoma VA Rating Criteria Guide

RatingScope resource

Eye Conditions C&P Exam & DBQ Guide

Guide to the official VA Eye Conditions Disability Benefits Questionnaire and clinical testing protocols.

Open Eye Conditions C&P Exam & DBQ Guide

Secondary conditions

Conditions commonly connected to Eye Conditions

No commonly documented secondary connections are tracked for Eye Conditions yet.

Educational Guides & Evidence Resources

In-depth analysis of DBQ forms, medical evidence thresholds, and rating schedules for Eye Conditions.

How VA Rates Eye Conditions: Visual Acuity, Field Loss, Cataracts, and Glaucoma Guide

Learn how the VA evaluates vision loss and eye diseases under 38 CFR 4.79, central visual acuity, visual field contraction, cataracts, and glaucoma ratings.

Eye Conditions C&P Exam & DBQ Guide: Evidence and Vision Testing

Understand the VA Eye Conditions Disability Benefits Questionnaire (DBQ), best-corrected Snellen acuity, Goldmann perimetry, diplopia, and incapacitating episodes.

Visual Acuity VA Rating Criteria: DC 6061-6066 Combined Eye Tables Guide

Learn how the VA evaluates central visual acuity loss under 38 CFR 4.75-4.77, Diagnostic Codes 6061-6066 paired-eye tables, and the single-eye 20/40 rule.

Visual Field Loss VA Rating: DC 6080 and DC 6081 Perimetry Tables Guide

Detailed analysis of VA peripheral vision loss ratings under 38 CFR 4.76, DC 6080 concentric contraction degrees, hemianopsia, and DC 6081 scotoma rules.

Diplopia and Eye Muscle Function VA Rating: DC 6090 Ocular Motility Guide

Understand how the VA rates double vision and extraocular muscle paralysis under 38 CFR 4.78 and DC 6090, quadrant weights, and visual acuity conversion.

Glaucoma VA Rating Criteria: DC 6012 and DC 6013 General Formula Guide

Detailed analysis of VA glaucoma ratings under 38 CFR 4.79, DC 6012 open-angle, DC 6013 angle-closure, continuous medication floor, and field loss.

Common VA Secondary Conditions to Diabetes: Neuropathy, Retinopathy, and Heart Disease

Learn the medical evidence required for claiming conditions secondary to diabetes under 38 CFR 3.310, including neuropathy, vision, and renal disease.

Agent Orange Presumptive Conditions: Qualifying Locations, Dates, and Diseases

Explore the complete list of Agent Orange presumptive conditions under 38 CFR 3.309(e), qualifying military service locations, and PACT Act expansions.

SMC-M, SMC-N, and SMC-O Explained: 38 CFR 3.350 Anatomical Combinations

Understand VA Special Monthly Compensation Levels M, N, and O under 38 CFR 3.350, evaluating severe multi-extremity loss, bilateral blindness, and combined awards.

Keep going

Compare a percentage level and combined-rating math, or review evidence context.

See all tools

VA Math & Combined Ratings

Understand the whole-person method, final rounding, and bilateral limits, then calculate how percentages combine.

Open VA Math guide

Evidence Center

Understand common evidence categories and what they can clarify without treating them as a checklist.

Open Evidence Center